Jacques Fantini

Jacques Fantini's AcademicInfluence.com Rankings

Jacques Fantini

Biology

#12675

World Rank

#16166

Historical Rank

Molecular Biology

#2081

World Rank

#2113

Historical Rank

Neuroscience

#2142

World Rank

#2202

Historical Rank

Biochemistry

#2179

World Rank

#2324

Historical Rank

biology Degrees

Download Badge

Biology

Jacques Fantini's Degrees

PhD Neuroscience Université Paris Cité

Why Is Jacques Fantini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jacques Fantini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection (2020) (434)
How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains (2013) (370)
CH-π hydrogen bonds in biological macromolecules. (2014) (307)
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. (1993) (249)
Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells (1992) (239)
Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins* (2002) (223)
Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases (2002) (220)
The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells. (2002) (220)
Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. (2009) (209)
The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. (2002) (197)
Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor (2011) (191)
Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. (2010) (166)
Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases (2010) (162)
Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. (2008) (147)
Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation. (2014) (137)
Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3* (1998) (134)
Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein (2016) (128)
Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3) (1999) (128)
Mutation Patterns of the Reverse Transcriptase and Protease Genes in Human Immunodeficiency Virus Type 1-Infected Patients Undergoing Combination Therapy: Survey of 787 Sequences (1999) (114)
The fusogenic tilted peptide (67-78) of α-synuclein is a cholesterol binding domain. (2011) (113)
Spontaneous and induced dome formation by two clonal cell populations derived from a human adenocarcinoma cell line, HT29. (1986) (111)
Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. (1994) (110)
Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion. (2011) (108)
Synthetic Soluble Analogs of Galactosylceramide (GalCer) Bind to the V3 Domain of HIV-1 gp120 and Inhibit HIV-1-induced Fusion and Entry* (1997) (107)
How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ1-40) (2010) (104)
A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes (2016) (100)
Co‐expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT‐29 (1997) (97)
Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997–2002) based on an analysis of over 7000 genotypes (2003) (93)
Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation (2013) (92)
Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4. (1989) (91)
How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains (2003) (91)
Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. (1991) (83)
Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. (1994) (82)
The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. (2001) (82)
Mechanism of cholesterol‐assisted oligomeric channel formation by a short Alzheimer β‐amyloid peptide (2014) (82)
Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. (2005) (78)
The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. (2009) (77)
Biochemical identification of a linear cholesterol-binding domain within Alzheimer's β amyloid peptide. (2013) (73)
Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line (1995) (72)
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal (2020) (72)
Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model. (2004) (71)
Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion (2000) (67)
Prediction of glycolipid-binding domains from the amino acid sequence of lipid raft-associated proteins: application to HpaA, a protein involved in the adhesion of Helicobacter pylori to gastrointestinal cells. (2006) (67)
Quantification of HIV‐1 viral load in lymphoid and blood cells: assessment during four‐drug combination therapy (1997) (65)
A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction DOI 10.1194/jlr.M200165-JLR200 (2002) (65)
A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection (2006) (65)
Structural dynamics of SARS-CoV-2 variants: A health monitoring strategy for anticipating Covid-19 outbreaks (2021) (65)
Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signal transduction pathways and perturbations of intestinal absorption and secretion (2000) (64)
Cell penetration properties of maurocalcine, a natural venom peptide active on the intracellular ryanodine receptor. (2006) (64)
Multidrug resistance genotypes (insertions in the beta3-beta4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: incidence and association with other resistance mutations. (2000) (64)
The driving force of alpha-synuclein insertion and amyloid channel formation in the plasma membrane of neural cells: key role of ganglioside- and cholesterol-binding domains. (2013) (64)
The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand (2008) (63)
The puzzling mutational landscape of the SARS‐2‐variant Omicron (2022) (63)
Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. (2010) (63)
Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides. (2014) (62)
SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. (1996) (62)
Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) domains. (2016) (62)
The virotoxin model of HIV-1 enteropathy: involvement of GPR15/Bob and galactosylceramide in the cytopathic effects induced by HIV-1 gp120 in the HT-29-D4 intestinal cell line. (2003) (61)
Induction of polarized apical expression and vectorial release of carcinoembryonic antigen (CEA) during the process of differentiation of HT29‐D4 cells (1989) (58)
Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29). (1985) (57)
Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion (1992) (57)
Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. (2001) (56)
Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. (1998) (55)
Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria? (2008) (54)
Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells. (1998) (54)
A Unifying Theory (2015) (54)
The Insertion and Transport of Anandamide in Synthetic Lipid Membranes Are Both Cholesterol-Dependent (2009) (53)
Metabolic changes in undifferentiated and differentiated human colon adenocarcinoma cells studied by multinuclear magnetic resonance spectroscopy. (1989) (51)
Cholesterol-Recognition Motifs in Membrane Proteins. (2019) (51)
Culture and identification of a “Deltamicron” SARS‐CoV‐2 in a three cases cluster in southern France (2022) (50)
Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy. (1997) (49)
Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale. (2001) (48)
Suramin inhibits proliferation of rat glioma cells and alters N‐cam cell surface expression (1990) (48)
Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium: bacterial targets linked to nutrient absorption. (2004) (48)
Notch ligand activity is modulated by glycosphingolipid membrane composition in Drosophila melanogaster (2010) (47)
The minimal amyloid‐forming fragment of the islet amyloid polypeptide is a glycolipid‐binding domain (2006) (47)
Production of insulin‐like growth factor II (IGF‐II) and different forms of IGF‐binding proteins by HT‐29 human colon carcinoma cell line (1990) (47)
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 (2020) (46)
Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth. (1992) (45)
Relevance of CARC and CRAC Cholesterol-Recognition Motifs in the Nicotinic Acetylcholine Receptor and Other Membrane-Bound Receptors. (2017) (44)
Deciphering the Glycolipid Code of Alzheimer's and Parkinson's Amyloid Proteins Allowed the Creation of a Universal Ganglioside-Binding Peptide (2014) (44)
A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. (2002) (44)
Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications. (2007) (42)
Brain Lipids in Synaptic Function and Neurological Disease: Clues to Innovative Therapeutic Strategies for Brain Disorders (2015) (42)
Intracellular calcium release induced by human immunodeficiency virus type 1 (HIV-1) surface envelope glycoprotein in human intestinal epithelial cells: a putative mechanism for HIV-1 enteropathy. (1995) (42)
Stable rearrangements of the β3–β4 hairpin loop of HIV‐1 reverse transcriptase in plasma viruses from patients receiving combination therapy (1998) (42)
Controlled aggregation of adenine by sugars: physicochemical studies, molecular modelling simulations of sugar-aromatic CH-pi stacking interactions, and biological significance. (2008) (37)
Multibranched V3 peptides inhibit human immunodeficiency virus infection in human lymphocytes and macrophages (1994) (37)
SPC3, a synthetic peptide derived from the V3 domain of human immunodeficiency virus type 1 (HIV-1) gp120, inhibits HIV-1 entry into CD4+ and CD4- cells by two distinct mechanisms. (1995) (37)
Mutation L210W of HIV-1 reverse transcriptase in patients receiving combination therapy. Incidence, association with other mutations, and effects on the structure of mutated reverse transcriptase. (2000) (36)
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? (2021) (36)
The Development of Na+-dependent Glucose Transport during Differentiation of an Intestinal Epithelial Cell Clone Is Regulated by Protein Kinase C (*) (1995) (35)
Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry. (2008) (34)
Sphingolipid-binding domain in the serotonin(1A) receptor. (2012) (33)
Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells. (1991) (33)
Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter (2018) (32)
Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers? (2020) (32)
Emergence in Southern France of a new SARS-CoV-2 variant of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein (2021) (30)
Glycolipids as potential binding sites for HIV: topology in the sperm plasma membrane in relation to the regulation of membrane fusion. (1998) (29)
In vitro differentiated HT 29‐D4 clonal cell line generates leakproof and electrically active monolayers when cultured in porous‐bottom culture dishes (1989) (28)
pH-dependent interaction of fumonisin B1 with cholesterol: physicochemical and molecular modeling studies at the air-water interface. (2002) (28)
Biophysical studies of the interaction of squalamine and other cationic amphiphilic molecules with bacterial and eukaryotic membranes: importance of the distribution coefficient in membrane selectivity. (2010) (28)
Comparison of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Mutations in HIV-1 Genomes Detected in Plasma and in Peripheral Blood Mononuclear Cells from Patients Receiving Combination Drug Therapy (1999) (27)
The combinatorial extension method reveals a sphingolipid binding domain on pancreatic bile salt-dependent lipase: role in secretion. (2004) (27)
Apical uptake and transepithelial transport of sphingosine monomers through intact human intestinal epithelial cells: physicochemical and molecular modeling studies. (2005) (27)
Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B (2019) (27)
From hopanoids to cholesterol: Molecular clocks of pentameric ligand-gated ion channels. (2016) (27)
Genetic analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variant. (2001) (26)
Intestinal absorption of the acetamiprid neonicotinoid by Caco-2 cells: Transepithelial transport, cellular uptake and efflux (2008) (25)
Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis. (1999) (25)
A cholesterol recognition motif in human phospholipid scramblase 1. (2014) (24)
HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection. (1998) (24)
Interferon-γ Decreases Cell Surface Expression of Galactosyl Ceramide, the Receptor for HIV-1 GP120 on Human Colonic Epithelial Cells (1994) (23)
Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium. (1990) (23)
The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature. (1987) (23)
Perturbations of glucose metabolism associated with HIV infection in human intestinal epithelial cells: a multinuclear magnetic resonance spectroscopy study (1997) (23)
Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4). (1988) (23)
Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma (2012) (23)
Characterization of an electrogenic sodium/glucose cotransporter in a human colon epithelial cell line (1995) (22)
Asymmetric Synthesis of Water‐Soluble Analogues of Galactosylceramide, an HIV‐1 Receptor: New Tools to Study Virus–Glycolipid Interactions (2002) (22)
C-Glycoside analogues of beta-galactosylceramide with a simple ceramide substitute: synthesis and binding to HIV-1 gp120. (2006) (20)
Hybrid In Silico/In Vitro Approaches for the Identification of Functional Cholesterol-Binding Domains in Membrane Proteins. (2017) (20)
Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide. (2000) (20)
Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose. (1990) (19)
Intracellular localisation of suramin, an anticancer drug, in human colon adenocarcinoma cells: a study by quantitative autoradiography. (1996) (19)
Replication and apical budding of HIV-1 in mucous-secreting colonic epithelial cells. (1992) (19)
Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. (2020) (19)
Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides. (2016) (18)
Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity. (2000) (18)
First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France (2022) (18)
Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions. (2000) (17)
A Glycosphingolipid Binding Domain Controls Trafficking and Activity of the Mammalian Notch Ligand Delta-Like 1 (2013) (17)
Characterization of galactosyl glycerolipids in the HT29 human colon carcinoma cell line. (2001) (17)
Evaluation of the effect of suramin on neural cell growth and N-CAM expression. (1990) (17)
Structural analysis of reverse transcriptase mutations at codon 215 explains the predominance of T215Y over T215F in HIV-1 variants selected under antiretroviral therapy. (2005) (16)
High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2 (2021) (16)
Amphiphilic anionic analogues of galactosylceramide: synthesis, anti-HIV-1 activity, and gp120 binding. (2001) (16)
GalCer, CD26 and HIV infection of intestinal epithelial cells. (1994) (16)
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease (2021) (15)
Analysis of individual purine and pyrimidine nucleoside di‐ and triphosphates and other cellular metabolites in PCA extracts by using multinuclear high resolution NMR spectroscopy (1996) (15)
The Virotoxin Model of HIV-1 Enteropathy: Involvement of GPR15/Bob and Galactosylceramide in the Cytopathic Effects Induced by HIV-1 gp120 in the HT-29-D4 Intestinal Cell Line (2003) (15)
The glycosphingolipid MacCer promotes synaptic bouton formation in Drosophila by interacting with Wnt (2018) (14)
A new method for the determination of specific 13C enrichment in phosphorylated [1-13C]glucose metabolites. 13C-coupled, 1H-decoupled 31P-NMR spectroscopy of tissue perchloric acid extracts. (1996) (14)
Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein (2022) (14)
HIV-1 transmission across the vaginal epithelium. (1997) (14)
Synthetic soluble analogs of glycolipids for studies of virus-glycolipid interactions. (2000) (13)
Mutations in HIV-1 gag cleavage sites and their association with protease mutations. (2001) (13)
Mapping of Domains on HIV Envelope Protein Mediating Association with Calnexin and Protein-disulfide Isomerase* (2010) (13)
Inhibition of human immunodeficiency virus infection in human colon epithelial cells by recombinant interferon‐γ (1992) (13)
Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicity. (1991) (13)
Suramin : a molecule with a broad spectrum of biological and therapeutic properties (1997) (12)
Energetic metabolism of glucose, mannose and galactose in glucose-starved rat insulinoma cells anchored on microcarrier beads. A phosphorus-31 NMR study. (1992) (12)
Non-lipolytic and lipolytic sequence-related carboxylesterases: a comparative study of the structure-function relationships of rabbit liver esterase 1 and bovine pancreatic bile-salt-activated lipase. (2010) (12)
Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells. (1994) (12)
Effect of vip on the glycogen metabolism of human colon adenocarcinoma cells studied by 13C nuclear magnetic resonance spectroscopy (1990) (11)
Monensin and tunicamycin-induced inhibition of HT29 cell spreading and growth. (1986) (11)
Selective transport of staphylococcal enterotoxin A through in vitro generated human M cells. (2007) (11)
Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity. (1991) (10)
Phosphorus-31 nuclear magnetic resonance study of the C6 glioma cell line cultured on microcarrier beads (1989) (10)
Ganglioside binding domains in proteins: Physiological and pathological mechanisms. (2022) (10)
Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes (2022) (10)
Multi-branched peptides based on the HIV-1 V3 loop consensus motif inhibit HIV-1 and HIV-2 infection in CD4+ and CD4- cells. (1993) (9)
Physical contact with lymphocytes is required for reactivation of dormant HIV-1 in colonic epithelial cells: involvement of the HIV-1 LTR. (1994) (9)
Characterization of the vasoactive intestinal peptide (VIP) binding sites: A biochemical and an immunological approach (1986) (9)
Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors. (1987) (9)
Tumor necrosis factor-alpha stimulates both apical and basal production of HIV in polarized human intestinal HT29 cells. (1992) (9)
A suramin derivative induces enterocyte‐like differentiation of human colon cancer cells without lysosomal storage disorder (1990) (8)
The Glycoprotein Nature of the Vasoactive Intestinal Peptide Binding Site. Role of Carbohydrates in VIP Binding on HT 29‐D4 Cells a (1988) (8)
A synthetic amino acid substitution of Tyr10 in Aβ peptide sequence yields a dominant negative variant in amyloidogenesis (2012) (8)
Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase. (2001) (8)
Aβ Behavior on Neuronal Membranes: Aggregation and Toxicities (2011) (8)
CD4 molecules are restricted to the basolateral membrane domain of in vitro differentiated human colon cancer cells (HT29‐D4) (1990) (8)
Total synthesis of mololipids: a new series of anti-HIV Moloka'iamine derivatives. (2000) (8)
Vectorial release of carcinoembryonic antigen induced by IFN-gamma in human colon cancer cells cultured in serum-free medium. (1991) (8)
Anandamide-ceramide interactions in a membrane environment: Molecular dynamic simulations data (2017) (8)
Kinetics of biochemical, electrophysiological and morphological events (including lysosomal disorder) during the course of suramin‐induced differentiation of the human colon‐cancer cell clone HT29‐D4 (1991) (8)
Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells. (2017) (8)
Interaction of cholesterol with sphingosine Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.M400199-JLR200 (2005) (7)
Gene Therapy Strategy for Alzheimer’s and Parkinson’s Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells (2021) (7)
Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides. (2011) (7)
The concentration of glucose in the culture medium determines the effect of suramin on the growth and differentiation of the human colonic adenocarcinoma cell clone HT29-D4. (1990) (7)
Endocannabinoids tune intrinsic excitability in O-LM interneurons by direct modulation of post-synaptic Kv7 channels. (2021) (7)
Short‐term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29‐D4 cells (1992) (7)
Autoradiographic localization of tritiated suramin in polarized human colon adenocarcinoma cells. (1993) (7)
The epigenetic dimension of protein structure (2022) (6)
Genetic determinants controlling HIV-1 tropism for CD4-/GalCer+ human intestinal epithelial cells (1996) (6)
The Epigenetic Dimension of Protein Structure Is an Intrinsic Weakness of the AlphaFold Program (2022) (6)
Chapter 7 – Lipid Regulation of Receptor Function (2015) (6)
Impaired carcinoembryonic antigen release during the process of suramin‐induced differentiation of the human colic adenocarcinoma cell clone HT29‐D4 (1990) (6)
Common Mechanisms in Neurodegenerative Diseases (2015) (5)
Differentiation in human colon tumor cells. Importance of autocrine growth factors (1992) (5)
V3 loop-derived multibranched peptides as inhibitors of HIV infection in CD4+ and CD4− cells (1996) (5)
How membrane lipids control the 3D structure and function of receptors (2018) (5)
Infection of HIV-1 and HIV-2 through the luminal and serosal sides of polarized human intestinal epithelial cells. (1992) (5)
Protein–Lipid Interactions in the Brain (2015) (5)
Comparison of the amyloid pore forming properties of rat and human Alzheimer’s beta-amyloid peptide 1-42: Calcium imaging data (2016) (5)
Cellular isoform of the prion protein PrPc in human intestinal cell lines: Genetic polymorphism at codon 129, mRNA quantification and protein detection in lipid rafts (2006) (5)
Growth in serum-free medium of human colonic adenocarcinoma cell lines on microcarriers: A two-step method allowing optimal cell spreading and growth (1987) (4)
A Vaccine Strategy Based on the Identification of an Annular Ganglioside Binding Motif in Monkeypox Virus Protein E8L (2022) (4)
Evidence for an ectophosvitin kinase activity that phosphorylates a 123 kDa endogenous substrate on a human colonic adenocarcinoma cell (HT 29). (1987) (4)
The novel hamster-adapted SARS-CoV-2 Delta variant may be selectively advantaged in humans. (2022) (4)
The emergence, spread and vanishing of a French SARS‐CoV‐2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule (2022) (4)
Therapeutic Strategies for Neurodegenerative Diseases (2015) (4)
Mutation L210W of HIV-1 Reverse Transcriptase in Patients Receiving Combination Therapy (2000) (3)
AmyP53, a Therapeutic Peptide Candidate for the Treatment of Alzheimer’s and Parkinson’s Disease: Safety, Stability, Pharmacokinetics Parameters and Nose-to Brain Delivery (2022) (3)
The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Black Queen rule (2022) (3)
Mechanisms of insulin action: by P. Belfrage, J. Donner and P. Stralfors. Elsevier/Fernström Foundations Series, Amsterdam, 1986, pp. 409, US$ 101.75 (1987) (3)
Structural variability ofenv andgag gene products from a highly cytopathic strain of HIV-1 (2005) (3)
Secondary structure predictions of HIV-1 reverse transcriptase provide new insights into the development of drug-resistance genotypes. (2001) (3)
Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France (2022) (3)
Role of spike compensatory mutations in the interspecies transmission of SARS-CoV-2 (2022) (3)
Co-localization of suramin and serum albumin in lysosomes of suramin-treated human colon cancer cells. (1996) (3)
Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium (2007) (2)
[The intestinal immune system. The VIP receptor on T lymphocytes: a new marker of differentiation?]. (1985) (2)
First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco (2022) (2)
Suramin: A polysulfonated compound that inhibits the binding of HIV-1 gp120 to GalCer/sulfatide and blocks the CD4-independent pathway of HIV-1 infection in mucosal epithelial cells (1996) (2)
Lipid Metabolism and Oxidation in Neurons and Glial Cells (2015) (2)
Detection of functional galactosylceramide (GalCer) receptors on CD4-negative HIV-1 target cells (1996) (2)
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects (2022) (2)
Galactosylceramide and transmembrane signalling in enterocytes: Calcium response induced by HIV-1 surface-envelope glycoprotein gp120 (1996) (1)
Biochemical and immunological approaches of the characterization of vasoactive intestinal peptide (VIP) receptors (1985) (1)
Chemical Basis of Lipid Biochemistry (2015) (1)
Combination of culture on collagen gels and glucose starvation for cloning human colon cancer cells (1991) (1)
AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer’s Disease Therapy (2023) (1)
Humanimmunodeficiency virus caninfect theapical and basolateral surfaces ofhumancolonic epithelial cells (1991) (1)
Inhibition of human immunodeficiency virus infection in human colon epithelial cells by recombinant interferon-gamma. (1992) (1)
Variations of Brain Lipid Content (2015) (1)
Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines. (1991) (1)
Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors (2023) (1)
Chapter 11 – Alzheimer’s Disease (2015) (1)
Review for "Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis" (2020) (0)
[The in vitro differentiation of cancer cells of the human colon (HT29-D4) is associated with the presence of annulate lamellae in the basal part of the cytoplasm]. (1990) (0)
Structural Basis of Botulinum Toxin Type F Binding to Glycosylated Human SV2A: In Silico Studies at the Periphery of a Lipid Raft (2022) (0)
Electrostatic Surface Potential as a Key Parameter in Virus Transmission and Evolution: How to Manage Future Virus Pandemics in the Post-COVID-19 Era (2023) (0)
Chapter 2 – Brain Membranes (2015) (0)
Contents Vol. 7, 2000 (2000) (0)
Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future (2023) (0)
All-atom Molecular Dynamics Simulation of botulinum neurotoxin serotype A1 in complex with human SV2A or SV2C receptors in a lipid raft environment (2022) (0)
A New Putative Cholesterol-Recognition Motif in Transmembrane Proteins (2012) (0)
Viral and Bacterial Diseases (2015) (0)
A Molecular View of the Synapse (2015) (0)
Polarized distribution of γ interferon-stimulated MHC antigens and transferrin receptors in a clonal cell line isolated from Fisher rat thyroid (FRT cells) (1993) (0)
Special lectures VIII. AIDS. (1992) (0)
Review for "The Structural Basis of Accelerated Host Cell Entry by SARS‐CoV‐2 †" (2020) (0)
SPC3, a nontoxic peptide inhibitor of HIV infection (1995) (0)
A study of viral populations by sequencing analysis of pol gene under triple combination therapy given at the time of primary HIV-1 infection (1999) (0)
A synthetic amino acid substitution of Tyr10 in Abeta peptide sequence acts as a dominant negative in amyloidogenesis (2011) (0)
Long-lasting reduction of intrinsic excitability in O-LM interneurons is mediated by endocannabinoid-dependent up-regulation of Kv7 channels (2021) (0)
Alternative Receptors for HIV-1 in Nervous System Tissues (1995) (0)
Creutzfeldt–Jakob Disease (2015) (0)
Erratum to: Cellular isoform of the prion protein PrPc in human intestinalcell lines: Genetic polymorphism at codon 129, mRNA quantification and protein detection in lipid rafts [30 (6) 559–567] (2008) (0)
Chapter 10 – Parkinson’s Disease (2015) (0)
The protein-binding pocket of Botulinum neurotoxin B accommodates a preassembled synaptotagmin / ganglioside complex (2021) (0)
RETROVIRUS INFECTION OF ENTEROCYTES: DO THEY OR DON'T THEY? (1992) (0)
Full-length title: Role of SARS-CoV-2 mutations in the evolution of the COVID-19 (2023) (0)
[Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6]. (1991) (0)
Morphological alterations associated with HIV infection of CD4 − /GalCer + human intestinal epithelial cells (1996) (0)
Therapeutic and Vaccine Strategies for Stopping the COVID-19 Pandemic Based on Structural and Molecular Modeling Studies of Virus-Ganglioside Interactions (2021) (0)
Lipid rafts and human diseases: why we need to target gangliosides. (2023) (0)
Title: Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) (2016) (0)
Rare spike E484K-harboring SARS-CoV-2 (2021) (0)
Molecular landscape of BoNT/B bound to a membrane-inserted synaptotagmin/ganglioside complex (2022) (0)
Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (alpha, beta, gamma, delta, lambda and mu) : a structural and molecular epidemiology study (2021) (0)
EPITHELIUM INTESTINAL ET VIH (1992) (0)
[Suramin induces lysosomal storage disorder in HT29-D4 cells during a mechanism of polarized endocytosis]. (1992) (0)
Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (from alpha to omicron) : a structural and molecular epidemiology study (2021) (0)
Subject Index Vol. 7, 2000 (2000) (0)
Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (alpha, beta, gamma, delta, lambda and µ) : a structural and molecular epidemiology study (2021) (0)
Total Synthesis of Mololipids: A New Series of Anti‐HIV Moloka′iamine Derivatives. (2001) (0)
CARBON-13 NMR STUDY OF (1-13C) LABELLED GLUCOSE METABOLISM IN HUMAN ADENOCARCINOMA HT 29 CELLS. (1987) (0)
Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jacques Fantini?

Jacques Fantini is affiliated with the following schools:

Université Paris Cité
Aix-Marseille University

Jacques Fantini's Academic­Influence.com Rankings

Jacques Fantini's Degrees

Why Is Jacques Fantini Influential?

Jacques Fantini's Published Works

Published Works

What Schools Are Affiliated With Jacques Fantini?

Jacques Fantini's AcademicInfluence.com Rankings